–Findings demonstrate a key advancement in the development of proprietary Camelina varieties tolerant to application…
–Findings demonstrate a key advancement in the development of proprietary Camelina varieties tolerant to application…
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical…
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical…
— Conference call to be held Monday, August 14, 2023, at 8:30 a.m. ET —…
— Conference call to be held Monday, August 14, 2023, at 8:30 a.m. ET —…
Los Gatos, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) — Aridis Pharmaceuticals, Inc. (OTC: ARDS), a…
Los Gatos, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) — Aridis Pharmaceuticals, Inc. (OTC: ARDS), a…
BOSTON, Aug. 02, 2023 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the…
BOSTON, Aug. 02, 2023 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the…
NEEDHAM, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company)…
NEEDHAM, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company)…
LEOPARD trial initiation follows recent positive data from OCS-01 eye drops from the Stage 1…
LEOPARD trial initiation follows recent positive data from OCS-01 eye drops from the Stage 1…
PRINCETON, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage…
PRINCETON, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage…
Three New IVL-Specific Diagnostic Related Groups (DRGs) with Increased Payments Go Into Effect October 1,…
Three New IVL-Specific Diagnostic Related Groups (DRGs) with Increased Payments Go Into Effect October 1,…
WARREN, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company”…
WARREN, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company”…